TELOGEN EFFLUVIUM
Clinical trials for TELOGEN EFFLUVIUM explained in plain language.
Never miss a new study
Get alerted when new TELOGEN EFFLUVIUM trials appear
Sign up with your email to follow new studies for TELOGEN EFFLUVIUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a daily drink stop hair loss? new study says maybe
Disease control CompletedThis study tested a drinkable food supplement for hair loss in 106 premenopausal women aged 18-40 with telogen effluvium (temporary hair thinning). Over 6 months, researchers measured changes in hair density and growth cycles using scalp imaging. The goal was to see if the natura…
Matched conditions: TELOGEN EFFLUVIUM
Phase: NA • Sponsor: Olistic Research Labs S.L. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Millet seed extract shows promise for female hair loss
Disease control CompletedThis study tested whether millet seed extract capsules could help women with a type of temporary hair loss called telogen effluvium. Sixty women took either the millet extract or a standard biotin supplement for 12 weeks. Researchers measured changes in hair growth using special …
Matched conditions: TELOGEN EFFLUVIUM
Phase: NA • Sponsor: Kasr El Aini Hospital • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Can a shampoo really help hair loss? new study says maybe
Symptom relief CompletedThis study looked at whether a special shampoo can reduce hair loss in adults with telogen effluvium or mild androgenetic alopecia. Forty people used the shampoo for 3 months. Researchers measured changes in hair length and thickness to see if the product helped.
Matched conditions: TELOGEN EFFLUVIUM
Sponsor: Lacer S.A. • Aim: Symptom relief
Last updated May 26, 2026 07:27 UTC
-
Hair loss breakthrough? new study tests latanoprost acid in women
Symptom relief CompletedThis study tested whether a cosmetic product containing latanoprost acid can improve hair growth in women aged 18-60 with female pattern hair loss or chronic telogen effluvium. 29 women applied one of three strengths of the product daily for 6 months. The main goal was to see if …
Matched conditions: TELOGEN EFFLUVIUM
Phase: NA • Sponsor: Medical University of Warsaw • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC